阿尔茨海默病:从早期病原体到新的治疗方法
Santosh Kumar Prajapati1,2, Arjit Pathak3, Puneet K Samaiya4
1Bhavdiya Institute of Pharmaceutical Sciences and Research, Ayodhya, UP, India.
Metabolic brain disease
|July 24, 2024
概括
阿尔茨海默病的研究正在推进新的生物标志物和检测方法. 像纳米疗法这样的创新为早期阿尔茨海默病的检测和护理提供了未来的治疗可能性.
科学领域:
- 神经学 神经学
- 生物化学 生化学
- 生物技术是生物技术.
背景情况:
- 阿尔茨海默氏病 (AD) 的病理生理学仍然难以捉摸,传统的生物标志物如β-粉样蛋白和化陶证明不足.
- 尽管面临挑战,但在AD研究中正在出现重大研究创新.
- 从1957年到2022年的综合文献综述突出了AD研究的发展趋势.
研究的目的:
- 提供有关阿尔茨海默病可靠生物标志物的最新进展的最新信息.
- 审查AD的新型检测技术和治疗策略.
- 探索新兴创新及其对AD诊断和治疗的潜在影响.
主要方法:
- 文学评论跨越了六十年 (1957-2022年).
- 分析新的生物标志物,包括微RNA,比 (Aβ37/Aβ42) 和状纤维状酸蛋白.
- 评估新的诊断工具,如自行管理的体外认知检查和量子/电化学生物传感器.
主要成果:
- 识别了许多新的生物标志物 (例如,糖酸脱酶,聚蛋白,微RNA,Aβ37/Aβ42),有助于早期发现AD.
- 神经血管单元功能障碍被认为是AD中神经元活动和脑血流之间的关键因素.
- 诊断方法的进步,包括自我管理的经认知检查,显示出比传统测试更好的早期检测能力.
结论:
- 新兴的生物标志物和先进的检测技术,如纳米体,代表了阿尔茨海默病管理的未来.
- 纳米异能物质对AD的同时诊断,检测和治疗充满希望.
- 非药理学策略也在阿尔茨海默病治疗中显示出有希望的结果,补充了药理学方法.
相关概念视频
01:26Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
01:22Alzheimer's Disease: Treatment
172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172
01:15Parkinson's Disease: Overview
512
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
512
01:30Dementia
110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
110
03:03Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
552
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
552